I Malbohán

1.4k total citations
51 papers, 1.2k citations indexed

About

I Malbohán is a scholar working on Pathology and Forensic Medicine, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, I Malbohán has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 10 papers in Obstetrics and Gynecology and 9 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in I Malbohán's work include Pregnancy and preeclampsia studies (10 papers), Multiple Sclerosis Research Studies (7 papers) and Gestational Diabetes Research and Management (7 papers). I Malbohán is often cited by papers focused on Pregnancy and preeclampsia studies (10 papers), Multiple Sclerosis Research Studies (7 papers) and Gestational Diabetes Research and Management (7 papers). I Malbohán collaborates with scholars based in Czechia, Romania and United States. I Malbohán's co-authors include L Fialová, Tomáš Zima, L Mikulíková, S Štípek, P Popov, Aleš Bartoš, Oto Mestek, Marta Kalousová, J Crkovská and Jana Švarcová and has published in prestigious journals such as PLoS ONE, Biological Psychiatry and American Heart Journal.

In The Last Decade

I Malbohán

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I Malbohán Czechia 18 319 240 149 148 128 51 1.2k
L Fialová Czechia 21 339 1.1× 319 1.3× 225 1.5× 152 1.0× 292 2.3× 62 1.5k
L Mikulíková Czechia 10 181 0.6× 154 0.6× 27 0.2× 62 0.4× 64 0.5× 23 646
Xu Teng China 26 176 0.6× 563 2.3× 29 0.2× 63 0.4× 272 2.1× 88 1.9k
Mamoru Ohkita Japan 25 206 0.6× 457 1.9× 78 0.5× 29 0.2× 537 4.2× 85 1.8k
Turgut Ulutin Türkiye 17 108 0.3× 309 1.3× 61 0.4× 19 0.1× 200 1.6× 67 1.1k
Jacqueline A. Frank United States 26 188 0.6× 781 3.3× 132 0.9× 21 0.1× 139 1.1× 72 1.8k
Subat Turdi United States 26 99 0.3× 700 2.9× 68 0.5× 54 0.4× 364 2.8× 37 1.6k
Adeline Tan Australia 12 120 0.4× 292 1.2× 23 0.2× 180 1.2× 195 1.5× 17 1.3k
Emilie Vessières France 21 75 0.2× 546 2.3× 68 0.5× 47 0.3× 337 2.6× 46 1.3k
P Stewart United Kingdom 17 46 0.1× 345 1.4× 86 0.6× 125 0.8× 128 1.0× 27 1.9k

Countries citing papers authored by I Malbohán

Since Specialization
Citations

This map shows the geographic impact of I Malbohán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Malbohán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Malbohán more than expected).

Fields of papers citing papers by I Malbohán

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Malbohán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Malbohán. The network helps show where I Malbohán may publish in the future.

Co-authorship network of co-authors of I Malbohán

This figure shows the co-authorship network connecting the top 25 collaborators of I Malbohán. A scholar is included among the top collaborators of I Malbohán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Malbohán. I Malbohán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fialová, L, et al.. (2020). Avidity of anti-phospholipid antibodies in relation to their levels. Central European Journal of Immunology. 45(2). 136–143.
2.
Fialová, L, et al.. (2013). Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis. Journal of Neuroimmunology. 262(1-2). 113–120. 41 indexed citations
3.
Fialová, L, Jana Švarcová, Aleš Bartoš, & I Malbohán. (2012). Avidity of anti-neurocytoskeletal antibodies in cerebrospinal fluid and serum. Folia Microbiologica. 57(5). 415–419. 11 indexed citations
4.
Fialová, L, Aleš Bartoš, Jana Švarcová, & I Malbohán. (2011). Increased Intrathecal High-Avidity Anti-Tau Antibodies in Patients with Multiple Sclerosis. PLoS ONE. 6(11). e27476–e27476. 22 indexed citations
5.
Kalousová, Marta, Marie Kratochvílová, S Sulková, et al.. (2009). Fibroblast Growth Factor 23 and Matrix-Metalloproteinases in Patients with Chronic Kidney Disease: Are They Associated with Cardiovascular Disease?. Kidney & Blood Pressure Research. 32(4). 276–283. 25 indexed citations
6.
Fialová, L, Jana Švarcová, Aleš Bartoš, et al.. (2009). Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. European Journal of Neurology. 17(4). 562–566. 40 indexed citations
8.
Švarcová, Jana, et al.. (2008). Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis. European Journal of Neurology. 15(11). 1173–1179. 17 indexed citations
9.
Bartoš, Aleš, et al.. (2007). Antibodies against light neurofilaments in multiple sclerosis patients. Acta Neurologica Scandinavica. 116(2). 100–107. 37 indexed citations
10.
Hodková, Magdaléna, S Sulková, Marta Kalousová, et al.. (2006). Influence of Oral Vitamin E Therapy on Micro-Inflammation and Cardiovascular Disease Markers in Chronic Hemodialysis Patients. Renal Failure. 28(5). 395–399. 27 indexed citations
11.
Fialová, L, I Malbohán, Marta Kalousová, et al.. (2006). Oxidative stress and inflammation in pregnancy. Scandinavian Journal of Clinical and Laboratory Investigation. 66(2). 121–128. 59 indexed citations
12.
Kalousová, Marta, et al.. (2005). T04-P-022 Advanced glycation and oxidation products in patients with atherosclerosis. Atherosclerosis Supplements. 6(1). 157–157. 8 indexed citations
13.
Fialová, L, Marta Kalousová, S Sulková, et al.. (2004). Relationship of Pregnancy-Associated Plasma Protein-A to Renal Function and Dialysis Modalities. Kidney & Blood Pressure Research. 27(2). 88–95. 39 indexed citations
14.
Fialová, L, Tomáš Zima, Vladimı́r Tesař, et al.. (2003). Antiphospholipid Antibodies in Patients with Lupus Nephritis. Renal Failure. 25(5). 747–758. 5 indexed citations
15.
Kalousová, Marta, S Sulková, L Fialová, et al.. (2003). Glycoxidation and inflammation in chronic haemodialysis patients. Nephrology Dialysis Transplantation. 18(12). 2577–2581. 50 indexed citations
16.
Fialová, L, L Mikulíková, I Malbohán, et al.. (2002). Antibodies against oxidised low density lipoproteins in pregnant women. Physiological Research. 355–361. 10 indexed citations
17.
Zima, Tomáš, L Fialová, Oto Mestek, et al.. (2001). Oxidative stress, metabolism of ethanol and alcohol-related diseases. Journal of Biomedical Science. 8(1). 59–70. 282 indexed citations
18.
Fialová, L, et al.. (1996). [Anti-phosphatidylinositol antibodies and their determination using our ELISA method].. PubMed. 97(4). 463–7. 1 indexed citations
19.
Fialová, L, I Malbohán, L Mikulíková, & Z Hájek. (1993). Biochemical screening of congenital developmental abnormalities using determination of fetoplacental antigens.. PubMed. 39(1-4). 3–8. 2 indexed citations
20.
Hájek, Z, et al.. (1984). [Prenatal care of genetically high risk pregnancies in the Central Bohemian Region].. PubMed. 49(1). 18–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026